BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8758899)

  • 1. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
    Tanaka S; Wands JR
    Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
    Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
    Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Chen RH; Su YH; Chuang RL; Chang TY
    Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
    Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
    Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.
    Zamorano J; Wang HY; Wang LM; Pierce JH; Keegan AD
    J Immunol; 1996 Dec; 157(11):4926-34. PubMed ID: 8943397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells.
    Banerjee K; Mohr L; Wands JR; de la Monte SM
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2093-101. PubMed ID: 9884156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the actin network in insulin signalling.
    Tsakiridis T; Wang Q; Taha C; Grinstein S; Downey G; Klip A
    Soc Gen Physiol Ser; 1997; 52():257-71. PubMed ID: 9210235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
    Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
    Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
    Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
    de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
    J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular growth inhibition by TGF-beta1 involves IRS proteins.
    Huang SS; Leal SM; Chen CL; Liu IH; Huang JS
    FEBS Lett; 2004 May; 565(1-3):117-21. PubMed ID: 15135063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines.
    Cuevas EP; Escribano O; Monserrat J; Martínez-Botas J; Sánchez MG; Chiloeches A; Hernández-Breijo B; Sánchez-Alonso V; Román ID; Fernández-Moreno MD; Guijarro LG
    J Cell Biochem; 2009 Dec; 108(6):1292-301. PubMed ID: 19795387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration.
    Sasaki Y; Wands JR
    Biochem Biophys Res Commun; 1994 Feb; 199(1):403-9. PubMed ID: 7510107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of apoptosis in hepatocellular carcinoma.
    Thorgeirsson SS; Teramoto T; Factor VM
    Semin Liver Dis; 1998; 18(2):115-22. PubMed ID: 9606809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin on TGF-beta 1-induced cell growth inhibition in the human hepatoma cell lines.
    Hung WC; Chuang LY; Tsai JH; Chang CC
    Biochem Mol Biol Int; 1993 Jul; 30(4):655-63. PubMed ID: 8401323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways for interleukin 4 and insulin in human hepatoma cells.
    Chuang LM; Tai TY; Kahn RC; Wu HP; Lee SC; Lin BJ
    J Biochem; 1996 Jul; 120(1):111-6. PubMed ID: 8864852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.